ARUP ASSOCIATES LIMITED

Company number 01312455 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: A- (Stable Hibernation)

Explanation: The company is not experiencing any financial distress; in fact, it is in a state of deliberate, managed suspended animation. Because the company is officially dormant and not actively trading, traditional financial metrics like profitability or liquidity are not applicable. However, its "vital signs" regarding corporate hygiene and compliance are excellent, and it benefits from the robust genetic lineage of the globally renowned Arup Group. The slight deduction from a perfect score reflects the inherent inertia of maintaining a non-trading entity.


Key Vital Signs

  • Heartbeat (Trading Activity): Flatline. The SIC code (74990 - Non-trading company) and the dormant accounts status confirm that this entity has no commercial pulse. It is not generating revenue, but importantly, it is also not accumulating operational debt. This is a controlled, intentional flatline rather than a sudden cardiac arrest.
  • Blood Pressure (Liabilities vs. Assets): Optimal. With a minimal share capital of £100 and dormant status, the company has virtually no financial pressure. There are no creditors squeezing the veins and no debt burden forcing the heart to work overtime.
  • Immune System (Compliance & Filing): Robust. The company’s regulatory immune system is functioning perfectly. Accounts are made up to date (March 2025) and the confirmation statement is up to date, with no filings currently overdue. It is successfully fighting off any threats of regulatory penalty or administrative dissolution.
  • DNA (Corporate Lineage): Elite. The People with Significant Control (PSC) register shows that the company is wholly owned and controlled by Ove Arup & Partners International Limited and Arup Group Limited. This means the entity has the full backing of a multibillion-pound global engineering consultancy, ensuring it will never suffer from malnutrition or a lack of institutional support.

Diagnosis

The patient is in a state of financial hibernation. Arup Associates Limited is a healthy but entirely inactive corporate entity. While its website points to the global Arup consultancy—which is highly active in shaping the built environment—this specific legal entity serves a structural, non-trading purpose within the wider corporate anatomy.

There are absolutely no symptoms of distress, insolvency, or maladministration. The directors maintain the company’s legal life signs through routine administrative care, ensuring it remains on the Companies House register without accumulating financial liabilities. It is essentially a dormant organ within the larger Arup Group body, preserved for strategic, historical, or legal reasons rather than commercial function.


Recommendations

Even a patient in hibernation requires routine care to ensure long-term wellness. I recommend the following preventative healthcare measures:

  1. Maintain Preventative Hygiene: Continue the excellent routine of filing annual dormant accounts and confirmation statements. A missed filing could lead to regulatory penalties or even forced dissolution, which would be akin to the patient unnecessarily catching a cold.
  2. Guard Against Corporate Identity Theft: Dormant companies are often targeted by fraudsters looking to hijack their corporate identity. Ensure that the registered office and director details are closely monitored, and consider implementing strict internal controls—similar to a healthy immune response—to detect any unauthorized filings.
  3. Evaluate the Need for Continued Hibernation: Periodically, the board of the parent group should review whether this entity still serves a strategic purpose. If the company is no longer needed as a structural vehicle, consider a voluntary strike-off. This would be the equivalent of a healthy lifestyle choice—shedding unnecessary administrative weight to reduce ongoing compliance costs.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 6 August 2026